Application of QbD in Process Development of Monoclonal Antibody for Therapeutic Use_Kaisong Zhou (Kaisong Zhou)
Created:
Apr 28, 2019 03:31 AM
| Last Modified: Jun 27, 2019 12:42 AM
Speaker: Zhou Kaisong , Vice President of Innovent Biopharma (Suzhou) Co., Ltd.
the speech topic: Application of QbD in process development of therapeutic monoclonal antibodies
Summary:
this speech Taking the process development of monoclonal antibody drugs as an example, the process development ideas and application cases guided by the QbD concept are introduced, and the implementation of JMP statistical software in process development is elaborated.
This post originally written in Chinese (Simplified) and has been translated for your convenience. When you reply, it will also be translated back to Chinese (Simplified).